Qiming Venture Partners is a venture capital firm investing in Technology&Consumer and Healthcare industries at the early and growth stages.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 480 fast-growing and innovative companies. Over 180 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 7, 2022
XellSmart
|
Series A | — | Biopharma | Yes |
Aug 26, 2022
Prismlab China Ltd
|
Series C | ¥200M | 3D Technology | Yes |
May 23, 2022
Point One
|
Series B | $36.80M | — | |
Mar 14, 2022
Medilink Therapeutics
|
Series B | $70M | Biotechnology | Yes |
Feb 8, 2022
NFTGo
|
Seed | $6.75M | Blockchain | Yes |